Publicação científica trimestral do CREMERJ - volume 2 - número 3 - 2023

58 Vacinação no idoso Ronaldo Rozenbaum Med. Ciên. e Arte , Rio de Janeiro, v.2, n.3, p.38-60, jul-set 2023 13. Silva PCR. Tese de Doutorado Biologia Celular e Molecular: Dinâmica Molecular dos vírus Influenza A (H1N1) Pandêmico em cinco anos de circulação no Brasil. 14. Christman MC, Kedwaii A, Xu J, Donis RO, Lu G. Pandemic (H1N1) 2009 virus revisited: An evolutionary retrospective. Infect Genet Evol. 2011; 11(5):803-11. 15. Medina RA, Garcia-Sastre A. Influenza A viruses: new research developments. Nat Rev Microbiol. 2011; 9(8):590-603. 16. Ministério da Saúde. Informe Técnico Operacional. Vacinação contra a Influenza; Brasília 2023. 17. Barros et al. Patterns of influenza B circulation in Brazil and its relevance to seasonal vaccine composition. Braz J Infect Dis 20 (1); 2016. doi.org/10.1016/j.bjid.2015.09.009 18. Influenza vaccines: the potential benefits of cell-culture isolation and manufacturing. Rajaram S, Boikos C, Gelone DK, and Gandhi A. Ther Adv Vaccines Immunother. 2020; 8: 2515135520908121. Published online 2020 Feb 22. DOI: 10.1177/2515135520908121. 19. Lee JKH, Lam GKL, Shin T, et al. Efficacy and effectiveness of high-dose influenza vaccine in older adults by circulating strain and antigenic match: An updated systematic review and meta- analysis. Vaccine 2021; 39 Suppl 1:A24. Supported by Sanofi Pasteur. 20. https://www.cdc.gov/flu/prevent/qa_fluzone.htm 21. https://www.uptodate.com/contents/seasonal-influenza-vaccination-in-adults?source= mostViewed_widget 22. Perdrizet J, et al. Cost-effectiveness analysis of replacing the 10-valent pneumococcal conjugate vaccine (PCV10) with the 13-valent pneumococcal conjugate vaccine (PCV13) in Brazil Infants. Human Vaccines & Immunotherapeutics. 2020; 17(4): 1162-1172. 23. Simell B, et al. Pneumococcal Carriage Group. The fundamental link between pneumococcal carriage and disease. Expert Review of Vaccines 2012; 11: 841-855. 24. Weiser JN, Ferreira DM, Paton JC. Streptococcus pneumoniae: transmission, colonization and invasion. Nat Rev Microbiol. 16(6):335-367, 2018. 25. Almeida S, et al. Low prevalence of Pneumococcal carriage and high serotype and genotype diversity among adults over 60 years of age living in Portugal. PLOS ONE. 9(3): e90974, 2014. 26. Arguedas A, et al. Upper Respiratory Tract Colonization with Streptococcus pneumoniae in adults. Expert Review of Vaccines. 19(4):353-366, 2020. 27. Centers for Disease Control and Prevention (CDC). 2020. National Center for Immunization and Respiratory Diseases, Division of Bacterial Diseases. Pneumococcal Disease. Disponível em: https://www.cdc.gov/ pneumococcal/clinicians/streptococcus-pneumoniae.html. Acesso em: 01 Jun 2021. 28. Krone CL, et al. Immunosenescence and pneumococcal disease: an imbalance in host pathogen inteactions. Lancet Respir Med 2014; 2:141-153. 29. Austrian R & Gold J. Pneumococcal bacteremia with special reference to bacteremic pneumococcal pneumonia. Ann. Intern. Med. 1964; 60:759-76. 30. Centers for Disease Control and Prevention (CDC). 2005. Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate on incidence of invasive pneumococcal disease-United States, 1998-2003. MMWR Morb Motal Wkly Rep. 54: 893 – 897, 2005. 31. Centers for Disease Control and Prevention (CDC). 2020. Biggest Threats and Data CDC’s Antibiotic Resistance Threats in the United States, 2019 (2019 AR Threats Report). DOI: https://www.cdc.gov/ drugresistance/biggest-threats.html Acesso em: 23.07.2021. 32. Paton JC, Trappetti C. Streptococcus pneumoniae capsular polysaccharide. Microbiol Spectrum 2018; 7(2): GPP3 - 0019. 33. Brueggemann AB, et al. Vaccine escape recombinants emerge after pneumococcal vaccination in the United States. PLoS Pathog. v. 3, n. 11, p. 11- 168. Nov. 2007 34. https://sbim.org.br/calendarios-de-vacinacao